Akso Health Group Sponsored ADR

AHG Healthcare Medical Distribution

Akso Health Group Sponsored ADR’s revenue for fiscal 2026 (year ended March 2026) was $13.8 million, down 6.40% from fiscal 2025.

1.35 0.00 0.00%
Market cap
$1.2B
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
112.75
Beneish M
n/a
Dividend safety
n/a

Akso Health Group Sponsored ADR (AHG) P/E ratio

Alert me on P/E ratio

Akso Health Group Sponsored ADR has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 30.7× (April 2019) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 0.0× —
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 27.8× 253.13%
FY2018 7.9× 5.33%
FY2017 7.5× 0.00%

Quarterly newest first

Period P/E ratio Change
Sep 2023 0.0× —
Mar 2023 0.0× —
Sep 2022 0.0× —
Mar 2022 0.0× —
14 more quarters

Against its own ten years

Low 0.0× High 30.7×
Ten-year median 0.0×
Current reading's percentile 82

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AHG